GO:0004663 Rab geranylgeranyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004663 describes the catalytic activity that attaches two geranylgeranyl groups to cysteine residues in Rab GTPases, a process called Rab geranylgeranylation.
• Rab geranylgeranyltransferase (RabGGTase) is a heterodimeric enzyme composed of an alpha and a beta subunit, and it requires an accessory protein, Rab escort protein (REP), to present Rab substrates.
• The reaction transfers two geranylgeranyl groups from geranylgeranyl diphosphate to the C-terminal cysteines of Rab proteins, forming thioether linkages.
• Defects in RabGGTase or its accessory proteins cause human diseases, including choroideremia, a retinal degeneration disorder linked to REP-1 mutations.
• RabGGTase is a potential therapeutic target in cancer and other diseases, and small-molecule inhibitors have been identified.
• Studying GO:0004663 requires biochemical assays, structural biology, and CRISPR-based models to dissect its role in health and disease.
Description
Rab geranylgeranyltransferase activity (GO:0004663) is a molecular function that catalyzes the transfer of two geranylgeranyl groups from geranylgeranyl diphosphate to cysteine residues near the C-terminus of Rab GTPases. This post-translational modification, known as geranylgeranylation, is essential for Rab proteins to associate with membranes and function in intracellular vesicle trafficking. The enzyme, often called RabGGTase or GGTase-II, is a heterodimer that works together with Rab escort protein (REP) to recognize and modify Rab substrates. Researchers study GO:0004663 because it is a key step in the prenylation pathway and because its dysfunction is linked to human diseases such as choroideremia, a progressive retinal degeneration caused by mutations in the REP-1 gene. In addition, RabGGTase has emerged as a target for therapeutic intervention in cancer and other conditions, driving efforts to develop specific inhibitors. Understanding the molecular mechanism, substrate specificity, and regulation of this enzyme is therefore of broad interest in cell biology, biochemistry, and drug discovery. This article provides a comprehensive overview of GO:0004663, covering its definition, biological importance, structural features, key genes, disease associations, and experimental approaches, including CRISPR-based models. All information is based on published literature and the QuickGO definition.
Rab geranylgeranyltransferase activity At A Glance
| GO ID | GO:0004663 |
|---|---|
| GO term | Rab geranylgeranyltransferase activity |
| Ontology | molecular_function |
| Synonym | GGTase-II activity; RabGGTase activity; protein geranylgeranyltransferase type II activity; type II protein geranyl-geranyltransferase activity |
| Major function | Catalyzes the transfer of two geranylgeranyl groups to cysteine residues in Rab GTPases, enabling membrane association and function. |
| Substrates | Rab family GTPases and Ras-related GTPases with C-terminal XXCC, XCXC, or CCXX motifs. |
| Cofactors | Geranylgeranyl diphosphate as the isoprenoid donor; Rab escort protein (REP) as an accessory factor. |
| Enzyme structure | Heterodimer of alpha and beta subunits; the beta subunit contains the catalytic site. |
| Disease relevance | Mutations in REP-1 cause choroideremia; RabGGTase is implicated in cancer and other diseases. |
What Is GO:0004663?
GO:0004663, Rab geranylgeranyltransferase activity, is defined as the catalysis of the reaction: 2 geranylgeranyl diphosphate + protein-cysteine = 2 S-geranylgeranyl-protein + 2 diphosphate. This reaction forms two thioether linkages between the C-1 atom of the geranylgeranyl groups and two cysteine residues within the terminal sequence motifs XXCC, XCXC, or CCXX of substrate proteins. Known substrates include Ras-related GTPases of a single family and the Rab family. Synonyms include GGTase-II activity, RabGGTase activity, and type II protein geranyl-geranyltransferase activity.
Why Is Rab geranylgeranyltransferase activity Important in Cell Biology?
Rab geranylgeranyltransferase activity is essential for the proper function of Rab GTPases, which regulate intracellular membrane trafficking, including vesicle formation, transport, and fusion. Without geranylgeranylation, Rab proteins cannot attach to membranes and carry out their roles, leading to defects in protein transport and cellular organization. This activity is also critical in specialized cells such as photoreceptors, where mutations in the Rab escort protein REP-1 cause choroideremia, a retinal degeneration disorder. Furthermore, RabGGTase is a promising drug target because its inhibition can affect cancer cell proliferation and survival, and specific inhibitors have been developed. Thus, understanding GO:0004663 has broad implications for basic cell biology and human disease.
• Essential for Rab GTPase function in membrane trafficking and vesicle transport.
• Required for photoreceptor maintenance; defects cause choroideremia.
• Plays a role in cancer cell growth and survival, making it a therapeutic target.
• Involved in the prenylation pathway that modifies Ras-related GTPases.
• Its inhibition can disrupt multiple cellular processes, offering opportunities for drug development.
• Studied in model organisms like Arabidopsis to understand substrate specificity and redundancy.
• Structural studies provide insights into mechanism and inhibitor design.
• Relevant to genetic diseases beyond choroideremia, including other retinal degenerations.
• Key to understanding how cells regulate protein localization and signaling.
• A model for studying enzyme-substrate recognition and accessory protein function.
What Happens During Rab geranylgeranyltransferase activity?
Substrate Recognition and REP-Mediated Presentation
In simple terms: The enzyme needs help to grab its target proteins, so a helper protein called REP brings the Rab to the enzyme.
Rab geranylgeranyltransferase (RabGGTase) does not act on Rab proteins alone; it requires an accessory protein called Rab escort protein (REP). REP binds to newly synthesized Rab GTPases and presents them to the enzyme, ensuring specificity and efficient modification. The REP-Rab complex then interacts with the RabGGTase heterodimer, positioning the C-terminal cysteines for catalysis.
Catalytic Transfer of Geranylgeranyl Groups
In simple terms: The enzyme attaches two fat-like geranylgeranyl groups to the Rab protein, which acts like a molecular anchor.
Once the Rab substrate is properly positioned, RabGGTase catalyzes the transfer of two geranylgeranyl groups from geranylgeranyl diphosphate to two cysteine residues in the C-terminal motif (XXCC, XCXC, or CCXX) of the Rab protein. This reaction forms thioether bonds, resulting in a doubly geranylgeranylated Rab protein. The enzyme uses a conserved mechanism involving a catalytic base and a zinc ion, although details may vary among prenyltransferases.
Product Release and Membrane Targeting
In simple terms: After modification, the Rab protein is released and can stick to cell membranes to do its job.
Following geranylgeranylation, the modified Rab protein is released from the enzyme-REP complex and can insert into cellular membranes via its lipid anchors. This membrane association is essential for Rab function in vesicle trafficking. REP may also play a role in delivering the modified Rab to specific membranes.
Substrate Specificity and Redundancy
In simple terms: The enzyme can modify many different Rab proteins, and in some organisms, there are multiple versions of the enzyme.
RabGGTase exhibits broad substrate specificity, modifying a wide range of Rab GTPases. In plants like Arabidopsis, multiple Rab geranylgeranyltransferases exist and show redundancy, ensuring efficient prenylation of diverse Rab substrates. This flexibility is crucial for the dynamic regulation of membrane trafficking.
Key Genes Involved in GO:0004663 Rab geranylgeranyltransferase activity
The following genes and proteins are key components or regulators of Rab geranylgeranyltransferase activity (GO:0004663).
| Gene | Major Role | Research Relevance |
|---|---|---|
| RABGGTA | Alpha subunit of RabGGTase; structural and regulatory role | Mutations or knockdown affect enzyme stability and function. |
| RABGGTB | Beta subunit of RabGGTase; contains catalytic site | Target for inhibitors; structural studies. |
| CHM (REP-1) | Rab escort protein 1; presents Rab substrates to RabGGTase | Mutations cause choroideremia. |
| CHML (REP-2) | Rab escort protein 2; alternative REP with overlapping function | Compensates for REP-1 loss in some tissues. |
| RAB1A | Rab GTPase substrate; regulates ER-to-Golgi transport | Model substrate for geranylgeranylation studies. |
| RAB3A | Rab GTPase substrate; synaptic vesicle trafficking | Used to study prenylation and membrane association. |
| RAB5A | Rab GTPase substrate; endosomal trafficking | Common substrate in in vitro assays. |
| RAB7A | Rab GTPase substrate; late endosome/lysosome transport | Implicated in disease; studied for prenylation. |
| RAB8A | Rab GTPase substrate; ciliary and secretory transport | Model for substrate specificity. |
| RAB11A | Rab GTPase substrate; recycling endosomes | Used in prenylation studies. |
| RAB27A | Rab GTPase substrate; melanosome and granule transport | Defects cause Griscelli syndrome; prenylation required. |
| GGPS1 | Geranylgeranyl diphosphate synthase; produces lipid donor | Provides substrate for RabGGTase. |
| FNTA | Farnesyltransferase alpha subunit; shares homology with RABGGTA | Comparative studies of prenyltransferases. |
| FNTB | Farnesyltransferase beta subunit; related enzyme | Contrast with RabGGTase specificity. |
| PGGT1B | Geranylgeranyltransferase I beta subunit; related enzyme | Distinct substrate specificity. |
| RABGGTA (Arabidopsis) | Plant RabGGTase alpha subunit | Studied for redundancy and substrate breadth. |
| RABGGTB (Arabidopsis) | Plant RabGGTase beta subunit | Functional studies in plants. |
How Is Rab geranylgeranyltransferase activity Regulated?
Rab geranylgeranyltransferase activity is regulated at multiple levels. The availability of geranylgeranyl diphosphate, produced by the mevalonate pathway, directly affects enzyme activity. The expression levels of the alpha and beta subunits and of REP proteins also influence overall activity. In some contexts, phosphorylation or other post-translational modifications may modulate enzyme function, although specific mechanisms are not fully defined. Additionally, substrate availability and the interaction with REP are critical for efficient catalysis.
Rab geranylgeranyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CHM (REP-1) | Choroideremia; retinal degeneration | CHM knockout iPSC-derived retinal organoids; point-mutation knock-in mice. |
| RABGGTB | Cancer; cell proliferation | RABGGTB knockout cancer cell lines; overexpression models. |
| RAB27A | Griscelli syndrome; immunodeficiency | RAB27A knockout melanocytes; knock-in of patient mutations. |
| RAB7A | Charcot-Marie-Tooth disease; neuropathy | RAB7A knockout neurons; point-mutation knock-in. |
| RABGGTA | Developmental defects; enzyme stability | RABGGTA knockout zebrafish; overexpression in cell lines. |
Choroideremia
Choroideremia is an X-linked retinal degeneration caused by mutations in the CHM gene, which encodes Rab escort protein 1 (REP-1). REP-1 is essential for presenting Rab substrates to RabGGTase, and its loss leads to defective geranylgeranylation of Rab proteins in the retina, resulting in progressive loss of photoreceptors and blindness. This disease highlights the critical role of GO:0004663 in retinal maintenance.
Cancer
Rab geranylgeranyltransferase activity is implicated in cancer because Rab GTPases regulate cell proliferation, migration, and survival. Inhibitors of RabGGTase have been developed and shown to affect cancer cell growth in preclinical studies, suggesting that targeting this activity could be a therapeutic strategy. However, the precise roles of individual Rab proteins in different cancers remain an active area of research.
Other Diseases Linked to Rab Prenylation
Defects in Rab geranylgeranylation have been associated with other conditions, including neurodegeneration and immune disorders, due to the broad roles of Rab proteins in membrane trafficking. For example, mutations in RAB27A, a Rab substrate, cause Griscelli syndrome, a rare immunodeficiency. Understanding GO:0004663 may provide insights into these diseases.
From Rab geranylgeranyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of RabGGTase loss on Rab prenylation? | RABGGTB knockout cell lines (e.g., HeLa, HEK293). |
| How do disease-causing mutations in REP-1 affect enzyme function? | CHM point-mutation knock-in iPSCs differentiated into retinal cells. |
| Can a specific Rab be tracked after geranylgeranylation? | Knock-in of tagged RAB (e.g., GFP-RAB11A) in cell lines. |
| What is the impact of RabGGTase overexpression on trafficking? | Overexpression of RABGGTA/RABGGTB in mammalian cells. |
| Which Rab proteins are substrates in a given cell type? | CRISPR library screening for Rab geranylgeranylation dependence. |
| How does RabGGTase inhibition affect cancer cell growth? | RABGGTB knockout or inhibitor treatment in cancer cell lines. |
How to Study the Rab geranylgeranyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro prenylation assay | Transfer of geranylgeranyl groups to Rab | Enzyme kinetics and inhibitor testing. |
| X-ray crystallography | Three-dimensional structure of RabGGTase | Mechanistic studies and inhibitor design. |
| Fluorescence microscopy | Subcellular localization of Rab proteins | Assessing geranylgeranylation-dependent membrane binding. |
| Western blot with anti-Rab antibodies | Shift in electrophoretic mobility upon prenylation | Detecting defects in Rab processing. |
| CRISPR knockout screening | Genes required for cell growth or Rab function | Identifying novel regulators of RabGGTase activity. |
| Mass spectrometry | Detection of geranylgeranylated peptides | Confirming modification sites on Rab proteins. |
| RNA-seq | Transcriptional changes upon RabGGTase loss | Understanding cellular responses. |
| Proteomics | Global changes in prenylated proteins | Identifying substrates and off-target effects. |
Biochemical Assays for Geranylgeranylation
In vitro assays using recombinant RabGGTase, REP, and Rab substrates can measure the transfer of radiolabeled geranylgeranyl groups. These assays are used to determine enzyme kinetics, substrate specificity, and inhibitor efficacy.
Structural Biology
X-ray crystallography and cryo-EM have provided high-resolution structures of RabGGTase alone and in complex with REP and Rab. These structures reveal the catalytic mechanism and guide the design of inhibitors.
Cell-Based Imaging
Fluorescence microscopy of GFP-tagged Rab proteins can assess their membrane localization, which depends on geranylgeranylation. Loss of RabGGTase activity leads to mislocalization of Rab proteins to the cytosol.
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes required for Rab geranylgeranylation and its downstream effects. Such screens help uncover synthetic lethal interactions and pathways that buffer against loss of RabGGTase activity.
How CRISPR Can Be Used to Study GO:0004663 Rab geranylgeranyltransferase activity
Knockout
CRISPR knockout of RABGGTA or RABGGTB eliminates RabGGTase activity, leading to mislocalization of Rab proteins and defects in membrane trafficking. These models are used to study the consequences of loss of function in cell lines and animal models.
Point Mutation
Introducing disease-associated point mutations (e.g., in CHM) via CRISPR knock-in allows researchers to study how specific amino acid changes affect REP-1 function and Rab geranylgeranylation. Such models are valuable for understanding choroideremia and for testing therapeutic strategies.
Knock-in
Knock-in of tagged Rab proteins (e.g., GFP-RAB11A) enables real-time tracking of geranylgeranylation and membrane targeting in live cells. This approach helps dissect the dynamics of Rab modification and trafficking.
Overexpression
Overexpression of RABGGTA and RABGGTB or of REP proteins can enhance geranylgeranylation and is used to study gain-of-function effects on trafficking and cell behavior. Overexpression models also help identify substrate specificity in different cell types.
How EDITGENE Supports Rab geranylgeranyltransferase activity Research
Researchers studying Rab geranylgeranyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in enzyme function, substrate recognition, or disease pathogenesis. CRISPR-based models provide a precise way to manipulate these genes and assess their roles in cellular processes and disease phenotypes.
Contact EDITGENE today to design your custom CRISPR model for Rab geranylgeranyltransferase activity research.
Frequently Asked Questions About Rab geranylgeranyltransferase activity
What is Rab geranylgeranyltransferase activity?
It is the enzymatic activity (GO:0004663) that attaches two geranylgeranyl groups to cysteine residues in Rab GTPases, enabling their membrane association and function.
What genes are involved in Rab geranylgeranyltransferase activity?
Key genes include RABGGTA and RABGGTB (encoding the enzyme subunits), CHM (REP-1), and various RAB genes that encode substrate GTPases.
What diseases are associated with Rab geranylgeranyltransferase activity?
Mutations in CHM cause choroideremia, a retinal degeneration; the activity is also implicated in cancer and other trafficking-related disorders.
How is Rab geranylgeranyltransferase activity regulated?
It is regulated by substrate availability, expression of enzyme subunits and REP proteins, and potentially by post-translational modifications.
What is the difference between RabGGTase and other prenyltransferases?
RabGGTase (GGTase-II) specifically modifies Rab GTPases and requires REP, whereas farnesyltransferase and GGTase-I modify other proteins like Ras.
Can Rab geranylgeranyltransferase be inhibited?
Yes, small-molecule inhibitors have been identified and are being explored for cancer therapy.
What model systems are used to study Rab geranylgeranyltransferase activity?
Common models include knockout cell lines, recombinant enzyme assays, and animal models such as mice and zebrafish.
How does Rab geranylgeranylation affect membrane trafficking?
Geranylgeranylation anchors Rab proteins to membranes, allowing them to regulate vesicle formation, transport, and fusion.
What are the substrates of Rab geranylgeranyltransferase?
Substrates are Rab family GTPases with C-terminal motifs XXCC, XCXC, or CCXX, as well as some Ras-related GTPases.
How can CRISPR be used to study Rab geranylgeranyltransferase activity?
CRISPR knockout, knock-in, and point mutation models allow precise manipulation of genes like RABGGTB and CHM to study their roles in geranylgeranylation and disease.
Conclusion
Rab geranylgeranyltransferase activity (GO:0004663) is a fundamental enzymatic function that controls the prenylation of Rab GTPases, thereby regulating intracellular membrane trafficking. Its importance is underscored by human diseases such as choroideremia and its potential as a cancer drug target. Continued research using biochemical, structural, and CRISPR-based approaches will further illuminate its mechanisms and therapeutic potential.
References
- 1. MacDonald IM et al.. 2004. Choroideremia gene testing.. Expert Rev Mol Diagn 4(4):478-84 PMID: 15225095
- 2. Watanabe M et al.. 2008. Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds.. J Biol Chem 283(15):9571-9 PMID: 18230616
- 3. Zhang H et al.. 2000. Crystal structure of Rab geranylgeranyltransferase at 2.0 A resolution.. Structure 8(3):241-51 PMID: 10745007
- 4. Marchwicka A et al.. 2022. Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization.. Int J Mol Sci 23(10) PMID: 35628237
- 5. Liang PH et al.. 2002. Structure, mechanism and function of prenyltransferases.. Eur J Biochem 269(14):3339-54 PMID: 12135472
- 6. Shi W et al.. 2016. Arabidopsis Rab Geranylgeranyltransferases Demonstrate Redundancy and Broad Substrate Specificity in Vitro.. J Biol Chem 291(3):1398-410 PMID: 26589801
- 8. Pereira-Leal JB et al.. 2001. Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic disease.. FEBS Lett 498(2-3):197-200 PMID: 11412856
